论文部分内容阅读
目的:观察妈富隆治疗围绝经期功能失调性子宫出血的临床效果。方法:将我科收治的116例围绝经期功能失调性子宫出血患者,根据临床前瞻性研究原则,随机分为2组,即:观察组予以妈富隆进行治疗,对照组予以米非司酮进行治疗。治疗后观察两组患者的疗效、子宫内膜厚度、阴道流血时间以及血红蛋白水平变化。结果:与对照组有效率比较,观察组患者有效率增加明显,子宫内膜厚度、阴道流血时间均降低明显,差异具有统计学意义(P<0.05)。结论:妈富隆治疗围绝经期功能失调性子宫出血可较好的改善患者的子宫内膜厚度,降低阴道流血时间,提高疗效。
Objective: To observe the clinical effect of Marvelon treating peri-menopausal dysfunctional uterine bleeding. Methods: One hundred and sixteen patients with dysfunctional uterine bleeding in climacteric period were randomly divided into 2 groups according to the clinical prospective study principle: the observation group was treated with Marvelon and the control group was given mifepristone treatment. After treatment, the curative effect, endometrial thickness, vaginal bleeding time and hemoglobin level in two groups were observed. Results: Compared with the control group, the effective rate of the observation group increased significantly, the thickness of the endometrium and vaginal bleeding time decreased significantly, the difference was statistically significant (P <0.05). Conclusion: Marvelon treatment of peri-menopausal dysfunctional uterine bleeding can better improve the patient’s endometrial thickness, reduce vaginal bleeding time and improve the curative effect.